Selected research
Industry Research
Human Rabies Vaccine Industry Research Report 2026
Market perspective
The global Human Rabies Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Human Rabies Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Human Rabies Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Human Rabies Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Human Rabies Vaccine include Zhuoyi Biological, ZhongKe Biopharm, Henan Grand Biopharma, Ningbo Rongan Biological, Prcmise, KANGH, Chengda Bio, Sanofi-Pasteur and Indian Immunologicals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Human Rabies Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Human Rabies Vaccine Market by Company
Zhuoyi Biological
ZhongKe Biopharm
Henan Grand Biopharma
Ningbo Rongan Biological
Prcmise
KANGH
Chengda Bio
Sanofi-Pasteur
Indian Immunologicals
Bharat Biotech
Bavarian Nordic
Human Rabies Vaccine Segment by Type
Vero Cell
BHK
Human Diploid Cells
Chick Embryo Cell
Others
Human Rabies Vaccine Segment by Application
Pre-Exposure Vaccine
Post-Exposure Vaccine
Human Rabies Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rabies Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Rabies Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Rabies Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Rabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vero Cell
- BHK
- Human Diploid Cells
- Chick Embryo Cell
- Others
Applications
- Pre-Exposure Vaccine
- Post-Exposure Vaccine
Companies covered
- Zhuoyi Biological
- ZhongKe Biopharm
- Henan Grand Biopharma
- Ningbo Rongan Biological
- Prcmise
- KANGH
- Chengda Bio
- Sanofi-Pasteur
- Indian Immunologicals
- Bharat Biotech
- Bavarian Nordic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Human Rabies Vaccine Market Size (2021-2032)
- 2.2.2 Global Human Rabies Vaccine Sales (2021-2032)
- 2.2.3 Global Human Rabies Vaccine Market Average Price (2021-2032)
- 2.3 Human Rabies Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Vero Cell
- 2.3.3 BHK
- 2.3.4 Human Diploid Cells
- 2.3.5 Chick Embryo Cell
- 2.3.6 Others
- 2.4 Human Rabies Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pre-Exposure Vaccine
- 2.4.3 Post-Exposure Vaccine
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Human Rabies Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Human Rabies Vaccine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Human Rabies Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Human Rabies Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Human Rabies Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Human Rabies Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Human Rabies Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Human Rabies Vaccine, Established Date
- 3.9 Global Human Rabies Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhuoyi Biological
- 4.1.1 Zhuoyi Biological Company Information
- 4.1.2 Zhuoyi Biological Business Overview
- 4.1.3 Zhuoyi Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhuoyi Biological Human Rabies Vaccine Product Portfolio
- 4.1.5 Zhuoyi Biological Recent Developments
- 4.2 ZhongKe Biopharm
- 4.2.1 ZhongKe Biopharm Company Information
- 4.2.2 ZhongKe Biopharm Business Overview
- 4.2.3 ZhongKe Biopharm Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 ZhongKe Biopharm Human Rabies Vaccine Product Portfolio
- 4.2.5 ZhongKe Biopharm Recent Developments
- 4.3 Henan Grand Biopharma
- 4.3.1 Henan Grand Biopharma Company Information
- 4.3.2 Henan Grand Biopharma Business Overview
- 4.3.3 Henan Grand Biopharma Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Henan Grand Biopharma Human Rabies Vaccine Product Portfolio
- 4.3.5 Henan Grand Biopharma Recent Developments
- 4.4 Ningbo Rongan Biological
- 4.4.1 Ningbo Rongan Biological Company Information
- 4.4.2 Ningbo Rongan Biological Business Overview
- 4.4.3 Ningbo Rongan Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ningbo Rongan Biological Human Rabies Vaccine Product Portfolio
- 4.4.5 Ningbo Rongan Biological Recent Developments
- 4.5 Prcmise
- 4.5.1 Prcmise Company Information
- 4.5.2 Prcmise Business Overview
- 4.5.3 Prcmise Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Prcmise Human Rabies Vaccine Product Portfolio
- 4.5.5 Prcmise Recent Developments
- 4.6 KANGH
- 4.6.1 KANGH Company Information
- 4.6.2 KANGH Business Overview
- 4.6.3 KANGH Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 KANGH Human Rabies Vaccine Product Portfolio
- 4.6.5 KANGH Recent Developments
- 4.7 Chengda Bio
- 4.7.1 Chengda Bio Company Information
- 4.7.2 Chengda Bio Business Overview
- 4.7.3 Chengda Bio Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Chengda Bio Human Rabies Vaccine Product Portfolio
- 4.7.5 Chengda Bio Recent Developments
- 4.8 Sanofi-Pasteur
- 4.8.1 Sanofi-Pasteur Company Information
- 4.8.2 Sanofi-Pasteur Business Overview
- 4.8.3 Sanofi-Pasteur Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sanofi-Pasteur Human Rabies Vaccine Product Portfolio
- 4.8.5 Sanofi-Pasteur Recent Developments
- 4.9 Indian Immunologicals
- 4.9.1 Indian Immunologicals Company Information
- 4.9.2 Indian Immunologicals Business Overview
- 4.9.3 Indian Immunologicals Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Indian Immunologicals Human Rabies Vaccine Product Portfolio
- 4.9.5 Indian Immunologicals Recent Developments
- 4.10 Bharat Biotech
- 4.10.1 Bharat Biotech Company Information
- 4.10.2 Bharat Biotech Business Overview
- 4.10.3 Bharat Biotech Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bharat Biotech Human Rabies Vaccine Product Portfolio
- 4.10.5 Bharat Biotech Recent Developments
- 4.11 Bavarian Nordic
- 4.11.1 Bavarian Nordic Company Information
- 4.11.2 Bavarian Nordic Business Overview
- 4.11.3 Bavarian Nordic Human Rabies Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bavarian Nordic Human Rabies Vaccine Product Portfolio
- 4.11.5 Bavarian Nordic Recent Developments
5 Global Human Rabies Vaccine Market Scenario by Region
- 5.1 Global Human Rabies Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Human Rabies Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Human Rabies Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Human Rabies Vaccine Sales by Region: 2027-2032
- 5.3 Global Human Rabies Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Human Rabies Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Human Rabies Vaccine Revenue by Region: 2027-2032
- 5.4 North America Human Rabies Vaccine Market Facts & Figures by Country
- 5.4.1 North America Human Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Human Rabies Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Human Rabies Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Human Rabies Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Human Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Human Rabies Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Human Rabies Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Human Rabies Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Human Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Human Rabies Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Human Rabies Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Human Rabies Vaccine Market Facts & Figures by Country
- 5.7.1 South America Human Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Human Rabies Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Human Rabies Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Human Rabies Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Human Rabies Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Human Rabies Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Human Rabies Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Human Rabies Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Human Rabies Vaccine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Human Rabies Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Human Rabies Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Human Rabies Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Human Rabies Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Human Rabies Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Human Rabies Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Human Rabies Vaccine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Human Rabies Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Human Rabies Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Human Rabies Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Human Rabies Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Human Rabies Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Human Rabies Vaccine Value Chain Analysis
- 8.1.1 Human Rabies Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Human Rabies Vaccine Production Mode & Process
- 8.2 Human Rabies Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Human Rabies Vaccine Distributors
- 8.2.3 Human Rabies Vaccine Customers
9 Global Human Rabies Vaccine Analyzing Market Dynamics
- 9.1 Human Rabies Vaccine Industry Trends
- 9.2 Human Rabies Vaccine Industry Drivers
- 9.3 Human Rabies Vaccine Industry Opportunities and Challenges
- 9.4 Human Rabies Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst